Biotech’s Bold Move: Inside Agenus’ Quest to Revolutionize Cancer Treatment
Agenus Inc. is advancing BOT/BAL therapy, aiming to revolutionize cancer treatment. BOT/BAL shows promise in combating microsatellite stable (MSS) colorectal cancer, a difficult-to-treat form. Strategic focus on BOT/BAL has led Agenus to reduce operational expenditures and monetize non-core assets. High-profile partnerships and
